<DOC>
	<DOC>NCT00700934</DOC>
	<brief_summary>The aim of this study is to describe the natural history of patients with alpha-1 antitrypsin associated emphysema and to figure out associated prognostic factors.</brief_summary>
	<brief_title>Management of Patients With Alpha-1 Antitrypsin Deficiency Associated Emphysema</brief_title>
	<detailed_description>All patients who suffer from this disease are followed every 6 months during a 5 years period. FEV1 decline is the primary endpoint. Quality of life assessed using the Saint George's Respiratory Questionary is recorded too.</detailed_description>
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<mesh_term>Alpha 1-Antitrypsin Deficiency</mesh_term>
	<mesh_term>Alpha 1-Antitrypsin</mesh_term>
	<mesh_term>Protein C Inhibitor</mesh_term>
	<criteria>Serum alpha one antitrypsin &lt; 0.8 g/l Emphysema diagnosed by CT scan Adult Obstructive disorder Liver or lung transplantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>FEV1</keyword>
	<keyword>mortality</keyword>
	<keyword>Quality of life</keyword>
</DOC>